Literature DB >> 1905123

Thrombosis in systemic lupus erythematosus: a French collaborative study.

M A Montes de Oca1, M C Babron, O Blétry, M Broyer, V Courtecuisse, J L Fontaine, C Loirat, J P Méry, P Reinert, B Wechsler.   

Abstract

A retrospective study was undertaken of 120 children with systemic lupus erythematosus (SLE) seen in Paris and its immediate suburbs who fulfilled at least four of the American College of Rheumatology diagnostic criteria for SLE, and in whom the disease was diagnosed before the age of 16 and between January 1975 and December 1987. Eleven of these children (eight girls and three boys) all more than 10 years of age (mean follow up 8.1 years; range 3-13) had thrombotic episodes (9%). Thrombosis was one of the presenting signs in seven patients; in five it was associated with typical symptoms of SLE, and in the other two the thrombotic episode was isolated and diagnosis of SLE was delayed one and three years. Of a total of 16 thrombotic episodes (six of which were recurrent), 14 involved the leg veins, and in four there was associated pulmonary embolism. There were two episodes that affected cerebral arteries. The American College of Rheumatology diagnostic criteria for SLE as well as the incidence of lupus anticoagulant, positive direct Coombs test, and vasculitis in this group of patients was compared with the incidence in patients with SLE but no thrombosis. Only lupus anticoagulant was significantly associated with thrombotic episodes: eight of 11 (73%) of patients with SLE and thrombotic (arterial or venous) episodes had lupus anticoagulant compared with only 10 of 74 patients (14%) with no history of thrombotic events in the same age group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905123      PMCID: PMC1793157          DOI: 10.1136/adc.66.6.713

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  28 in total

1.  THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS.

Authors:  E J BOWIE; J H THOMPSON; C A PASCUZZI; C A OWEN
Journal:  J Lab Clin Med       Date:  1963-09

2.  Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.

Authors:  D Alarcón-Segovia; M Delezé; C V Oria; J Sánchez-Guerrero; L Gómez-Pacheco; J Cabiedes; L Fernández; S Ponce de León
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

3.  Antiphospholipid antibodies: an elderly statesman Dons new garments.

Authors:  E N Harris; G R Hughes; A E Gharavi
Journal:  J Rheumatol Suppl       Date:  1987-06

Review 4.  Cerebral and valve lesions in SLE: association with antiphospholipid antibodies.

Authors:  R A Asherson; W F Lubbe
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

Review 5.  Acquired inhibitors of blood coagulation.

Authors:  D I Feinstein; S I Rapaport
Journal:  Prog Hemost Thromb       Date:  1972

6.  Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.

Authors:  R H Derksen; P Hasselaar; L Blokzijl; F H Gmelig Meyling; P G De Groot
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

7.  Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus.

Authors:  P M Ford; S E Ford; D P Lillicrap
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

8.  Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies.

Authors:  P Pelkonen; O Simell; V Rasi; O Vaarala
Journal:  Acta Paediatr Scand       Date:  1988-09

Review 9.  Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon.

Authors:  D A Triplett; J T Brandt
Journal:  Hematol Pathol       Date:  1988

10.  Ischemic stroke in a girl with lupus anticoagulant.

Authors:  R E Kelley; J R Berger
Journal:  Pediatr Neurol       Date:  1987 Jan-Feb       Impact factor: 3.372

View more
  11 in total

1.  An unusual case of renal failure. The renal biopsy changes were typical of lupus nephritis.

Authors:  R M Beattie; B Hartley; A G Clark; S P Rigden
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

Review 2.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 3.  Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review.

Authors:  Qiang Lin; Man Zhang; Hanyun Tang; Yunyan Shen; Yun Zhu; Qinying Xu; Xiaozhong Li
Journal:  Rheumatol Int       Date:  2019-08-03       Impact factor: 2.631

4.  Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India.

Authors:  Jasmina Ahluwalia; Surjit Singh; Gurjeewan Garewal
Journal:  Rheumatol Int       Date:  2004-08-25       Impact factor: 2.631

5.  Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis.

Authors:  R Caporali; A Ravelli; B Ramenghi; C Montecucco; A Martini
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

6.  Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: a case report.

Authors:  N Besbas; I Damarguc; S Ozen; S Aysun; U Saatci
Journal:  Eur J Pediatr       Date:  1994-12       Impact factor: 3.183

Review 7.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

Review 8.  Antiphospholipid antibodies in paediatrics.

Authors:  A Ravelli; A Martini; G R Burgio
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

Review 9.  Hemostatic complications in renal disorders of the young.

Authors:  M Andrew; L A Brooker
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

10.  Cerebrovascular complications in pediatric intensive care unit.

Authors:  Anil Sachdev; Rachna Sharma; Dhiren Gupta
Journal:  Indian J Crit Care Med       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.